Your fact-checks will appear here
Treatment of strongyloidiasis with ivermectin
Ivermectin dosing for human parasitic infections is weight-based, most commonly prescribed at about 200 micrograms per kilogram (mcg/kg) as a single oral dose for strongyloidiasis and many scabies reg...
Ivermectin dosing for human parasitic infections is weight-based and generally expressed in micrograms per kilogram (mcg/kg); the usual therapeutic range for common infections is about 150–200 mcg/kg ...
The FDA‑label prescribing information for STROMECTOL (ivermectin) specifies dosing by indication: a single oral dose of approximately 200 mcg/kg for intestinal strongyloidiasis and approximately 150 m...
Clinicians must identify or exclude high Loa loa microfilaremia before giving ivermectin in endemic areas because serious adverse events—including encephalopathy and death—are tightly linked to high c...
Ivermectin is an effective, evidence-based antiparasitic for specific human infections — notably onchocerciasis and strongyloidiasis — when used at approved doses under medical supervision . It is not...
Repeating ivermectin is routine for onchocerciasis (often yearly) and sometimes necessary for strongyloidiasis—especially in immunocompromised patients—but repetition brings predictable risks that can...
Reports and case-series show multiple instances where people ingested veterinary ivermectin formulations — most commonly during the COVID-19 pandemic — producing a spectrum of outcomes from mild gastr...